HCV evolving in hepatoma cells in culture can find multiple mutation pathways to acquire resistance to IFN-α, and resistant HCV populations display decreased sensitivity to a IFN-α+Rib combination treatment [12]. The gene discussed is IFNA1; the disease is hepatocellular carcinoma.